Corrigendum to “Conditional reprogrammed human limbal epithelial cell model for anti-SARS-CoV-2 drug screening” [Heliyon Volume 10, Issue 9 , 15 May 2024, e30044]
Yu Xiao,
Ling Wang,
Shi-xu Li,
Shi-song Fang,
Fan Luo,
Shu-liang Chen,
Xuan Zou,
Lin Ye,
Wei Hou
Affiliations
Yu Xiao
Shenzhen Research Institute, Wuhan University, Shenzhen, 518057, Guangdong Province, China; Department of Clinical Laboratory, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, 518107, China
Ling Wang
Shenzhen Eye Hospital, Shenzhen, 518040, Guangdong Province, China
Shi-xu Li
Shenzhen Eye Hospital, Shenzhen, 518040, Guangdong Province, China
Shi-song Fang
Shenzhen Center for Disease Control and Prevention, Shenzhen, 518055, Guangdong Province, China
Fan Luo
State Key Laboratory of Virology/Institute of Medical Virology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China
Shu-liang Chen
State Key Laboratory of Virology/Institute of Medical Virology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China
Xuan Zou
Shenzhen Center for Disease Control and Prevention, Shenzhen, 518055, Guangdong Province, China; Corresponding author.
Shenzhen Research Institute, Wuhan University, Shenzhen, 518057, Guangdong Province, China; State Key Laboratory of Virology/Institute of Medical Virology, School of Basic Medical Sciences, Wuhan University, Wuhan, 430071, Hubei Province, China; Corresponding author. Shenzhen Research Institute, Wuhan University, Shenzhen, 518057, Guangdong Province, China
